These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6108271)

  • 1. Physiologic effects of epinephrine on glucose turnover and plasma free fatty acid concentrations mediated independently of glucagon.
    Gray DE; Lickley HL; Vranic M
    Diabetes; 1980 Aug; 29(8):600-8. PubMed ID: 6108271
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of epinephrine and somatostatin-induced insulin deficiency on ketone body kinetics and lipolysis in man.
    Weiss M; Keller U; Stauffacher W
    Diabetes; 1984 Aug; 33(8):738-44. PubMed ID: 6146545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of somatostatin on plasma cyclic AMP and metabolic substrate responses to i.v. adrenaline and glucagon in humans.
    Nistrup Madsen S; Christensen SE; Hansen AP; Thode J
    Clin Endocrinol (Oxf); 1981 Nov; 15(5):431-7. PubMed ID: 6120054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epinephrine's effect on metabolic rate is independent of changes in plasma insulin or glucagon.
    Staten MA; Matthews DE; Cryer PE; Bier DM
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E185-92. PubMed ID: 2569829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State of metabolic control determines role of epinephrine-glucagon interaction in glucoregulation in diabetes.
    Kemmer FW; Lickley HL; Gray DE; Perez G; Vranic M
    Am J Physiol; 1982 Jun; 242(6):E428-36. PubMed ID: 6124126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of exogenous glucagon and epinephrine in physiological amounts on the blood levels of free fatty acids and glycerol in dogs.
    Muller WA; Aoki TT; Egdahl RH; Cahill GF
    Diabetologia; 1977 Jan; 13(1):55-8. PubMed ID: 838203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glucagon in mediating metabolic effects of epinephrine.
    Chideckel EW; Goodner CJ; Koerker DJ; Johnson DG; Ensinck JW
    Am J Physiol; 1977 May; 232(5):E464-70. PubMed ID: 404888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of somatostatin on epinephrine-induced free fatty acid release in normal man.
    Botha JL; Vinik AI; Child P; Lund A; van Tonder S
    S Afr Med J; 1977 Dec; 52(25):995-7. PubMed ID: 607511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of epinephrine, dibutyryl cyclic AMP, and glucagon infused intravenously into normal dogs.
    Altszuler N; Morrison A; Steele R; Bjerknes C
    Ann N Y Acad Sci; 1971 Dec; 185():101-7. PubMed ID: 4330483
    [No Abstract]   [Full Text] [Related]  

  • 10. Catecholamine responses and their interactions with other glucoregulatory hormones.
    Vranic M; Gauthier C; Bilinski D; Wasserman D; El Tayeb K; Hetenyi G; Lickley HL
    Am J Physiol; 1984 Aug; 247(2 Pt 1):E145-56. PubMed ID: 6147092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma free fatty-acid response and adrenal medullary and cortical secretion following glucagon injections.
    Fujii K; Tamura Y; Matsui N; Ishihara I
    Annu Rep Res Inst Environ Med Nagoya Univ; 1969; 17():1-13. PubMed ID: 5385341
    [No Abstract]   [Full Text] [Related]  

  • 12. Calorigenic effects of glucagon and epinephrine in anesthetized dogs.
    Weiser PC; Grande F
    Proc Soc Exp Biol Med; 1974 Mar; 145(3):912-7. PubMed ID: 4818607
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of somatostatin on nonesterified fatty acid levels modifies glucose homeostasis during fasting.
    Hendrick GK; Frizzell RT; Cherrington AD
    Am J Physiol; 1987 Oct; 253(4 Pt 1):E443-52. PubMed ID: 2889364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glucagon and glucose load on glucose kinetics, plasma FFA, and insulin in dogs treated with methylprednisolone.
    Issekutz B; Borkow I
    Metabolism; 1973 Jan; 22(1):39-49. PubMed ID: 4681842
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of somatostatin on glucagon- and epinephrine-stimulated hepatic glucose output in the dog.
    Saccà L; Sherwin R; Felig P
    Am J Physiol; 1979 Feb; 236(2):E113-7. PubMed ID: 420283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin modulation of pancreatic glucagon, insulin, glucose and free fatty acids following beta-adrenergic stimulation.
    Raptis S; Escobar-Jimenez F; Rosenthal J; Ditschuneit HH; Pfeiffer EF
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1088-93. PubMed ID: 874045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important role of glucagon during exercise in diabetic dogs.
    Wasserman DH; Lickley HL; Vranic M
    J Appl Physiol (1985); 1985 Oct; 59(4):1272-81. PubMed ID: 2865245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
    Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
    Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective insulin or glucagon deficiency on glucose turnover.
    Lickley HL; Ross GG; Vranic M
    Am J Physiol; 1979 Mar; 236(3):E255-62. PubMed ID: 426056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.